Chemotherapy with Idarubicin, Ara-C,VP-16, Amsacrine, Followed by G-CSF and Maintenance Immunotherapy with Interleukin-2 for Patients with High-Risk Acute Myeloid leukemia: a 3-Years Follow-Up
暂无分享,去创建一个
A. Ganser | W. Hofmann | W. Brockhaus | L. Bergmann | T. Ittel | K. Höffken | G. Heil | O. Ottmann | A. Knuth | D. Hoelzer | G. Seipelt | N. Brack | M. Klausmann | K. Kolbe | W. Langer | J. Fischer | H. Fuhr | C. Zander